|
Tekla Healthcare Investors (HQH) DCF Valuation |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
Tekla Healthcare Investors (HQH) Bundle
Explore the financial potential of Tekla Healthcare Investors (HQH) with our user-friendly DCF Calculator! Enter your assumptions regarding growth, margins, and costs to determine the intrinsic value of Tekla Healthcare Investors (HQH) and inform your investment strategy.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8,9 | 6,5 | 8,3 | 10,3 | 10,8 | 11,6 | 12,4 | 13,3 | 14,3 | 15,3 |
| Revenue Growth, % | 0 | -27.46 | 27.63 | 24.44 | 4.64 | 7.31 | 7.31 | 7.31 | 7.31 | 7.31 |
| EBITDA | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 |
| EBITDA, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2,0 | 6,2 | 3,7 | 1,2 | ,2 | 4071511.85 | 4369203.54 | 4688661.22 | 5031476.25 | 5399356.29 |
| Depreciation, % | 22.07 | 96.14 | 44.38 | 11.52 | 2.05 | 35.23 | 35.23 | 35.23 | 35.23 | 35.23 |
| EBIT | -2,0 | -6,2 | -3,7 | -1,2 | -,2 | -4071511.85 | -4369203.54 | -4688661.22 | -5031476.25 | -5399356.29 |
| EBIT, % | -22.07 | -96.14 | -44.38 | -11.52 | -2.05 | -35.23 | -35.23 | -35.23 | -35.23 | -35.23 |
| Total Cash | ,0 | ,0 | ,0 | ,0 | ,0 | 614.9 | 659.85 | 708.1 | 759.87 | 815.43 |
| Total Cash, percent | ,0 | 0.0144283 | 0.0095759 | 0.00207932 | 0.000519998685 | 0.0053207 | 0.0053207 | 0.0053207 | 0.0053207 | 0.0053207 |
| Account Receivables | 4,3 | 4,0 | 2,9 | 6,9 | ,5 | 5008325.21 | 5374512.73 | 5767474.36 | 6189167.64 | 6641693.12 |
| Account Receivables, % | 48.38 | 62.43 | 34.67 | 66.6 | 4.6 | 43.34 | 43.34 | 43.34 | 43.34 | 43.34 |
| Inventories | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 |
| Inventories, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payable | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 |
| Accounts Payable, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditure | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 |
| Capital Expenditure, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -2,0 | -6,2 | -3,7 | -1,2 | -,2 | -4071511.85 | -4369203.54 | -4688661.22 | -5031476.25 | -5399356.29 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -4,3 | ,3 | 1,2 | -4,0 | 6,4 | -4512687.21 | -366187.52 | -392961.63 | -421693.28 | -452525.48 |
| WACC, % | 7.12 | 7.12 | 7.12 | 7.12 | 7.12 | 7.12 | 7.12 | 7.12 | 7.12 | 7.12 |
| PV UFCF | ||||||||||
| SUM PV UFCF | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 | ,0 | -5493069.27 |
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | -9 | |||||||||
| Present Terminal Value | -6 | |||||||||
| Enterprise Value | -12 | |||||||||
| Net Debt | 0 | |||||||||
| Equity Value | -12 | |||||||||
| Diluted Shares Outstanding, MM | 52 | |||||||||
| Equity Value Per Share | -0.23 |
What Awaits You
- Customizable Excel Template: A fully adaptable Excel-based DCF Calculator featuring pre-populated financial data for Tekla Healthcare Investors (HQH).
- Real Data Insights: Access to historical figures and future projections (displayed in the highlighted cells).
- Adjustable Forecasts: Modify assumptions such as revenue growth rates, EBITDA margins, and WACC.
- Instant Calculations: Quickly observe how your inputs influence the valuation of Tekla Healthcare Investors (HQH).
- Professional Resource: Designed for the needs of investors, CFOs, consultants, and financial analysts.
- Intuitive Layout: Organized for simplicity and ease, complete with detailed instructions for guidance.
Key Features
- Comprehensive HQH Data: Loaded with Tekla Healthcare Investors’ historical performance metrics and future growth forecasts.
- Fully Customizable Parameters: Tailor revenue growth rates, expense margins, WACC, tax rates, and capital expenditures to fit your analysis.
- Adaptive Valuation Framework: Seamless updates to Net Present Value (NPV) and intrinsic value based on your customized inputs.
- Scenario Analysis: Develop various forecasting scenarios to explore different valuation possibilities.
- User-Friendly Interface: Intuitive design crafted for both industry professionals and newcomers.
How It Operates
- Download: Get the comprehensive Excel file featuring Tekla Healthcare Investors’ (HQH) financial data.
- Customize: Fine-tune your projections by adjusting parameters such as revenue growth, EBITDA %, and WACC.
- Automatically Update: Watch as the intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Build various projections and instantly compare the results.
- Make Informed Decisions: Utilize the valuation outcomes to steer your investment strategy.
Why Opt for This Calculator?
- All-in-One Solution: Features DCF, WACC, and various financial ratio analyses seamlessly integrated.
- Adjustable Variables: Modify the yellow-highlighted cells to explore different investment scenarios.
- In-Depth Analysis: Automatically computes the intrinsic value and Net Present Value for Tekla Healthcare Investors (HQH).
- Preloaded Information: Comes with historical and projected data to provide reliable starting points.
- High-Caliber Design: Perfect for financial analysts, investors, and business consultants looking to evaluate (HQH).
Who Should Benefit from Tekla Healthcare Investors (HQH)?
- Investors: Assess the fair value of Tekla Healthcare Investors (HQH) to inform your investment choices.
- CFOs: Utilize a high-quality DCF model for accurate financial reporting and analysis.
- Consultants: Easily customize the template for client valuation reports.
- Entrepreneurs: Discover valuable insights into financial modeling employed by leading healthcare funds.
- Educators: Employ this resource as a teaching aid to illustrate valuation techniques.
What the Template Includes
- Historical Data: Contains Tekla Healthcare Investors' past financial results and baseline projections.
- DCF and Levered DCF Models: Comprehensive templates for calculating the intrinsic value of Tekla Healthcare Investors (HQH).
- WACC Sheet: Pre-constructed calculations for the Weighted Average Cost of Capital.
- Editable Inputs: Customize essential drivers such as growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A thorough overview of Tekla Healthcare Investors' financial statements.
- Interactive Dashboard: Dynamically visualize valuation outcomes and projections.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.